AbbVie (ABBV) Interest Expenses (2012 - 2016)

AbbVie (ABBV) has 5 years of Interest Expenses data on file, last reported at $245.0 million in Q2 2016.

• Interest Expenses for Q2 2016 came in at $245.0 million, up 42.44% year-over-year; the trailing twelve-month figure through Mar 2017 was $245.0 million (down 69.45% YoY), and the FY2015 annual result was $719.0 million, up 67.6% from the prior year.
• Interest Expenses grew to $245.0 million in Q2 2016 per ABBV's latest filing, from $215.0 million in the prior quarter.
• Over five years, Interest Expenses peaked at $245.0 million in Q2 2016 and troughed at $10.0 million in Q3 2012.
• A 5-year average of $125.8 million and a median of $113.0 million in 2012 frame the typical range for Interest Expenses.
• On a YoY basis, Interest Expenses climbed as much as 650.0% in 2013 and fell as far as 21.28% in 2013.
• A 5-year view of Interest Expenses shows it stood at $94.0 million in 2012, then decreased by 21.28% to $74.0 million in 2013, then soared by 87.84% to $139.0 million in 2014, then jumped by 49.64% to $208.0 million in 2015, then advanced by 17.79% to $245.0 million in 2016.
• Business Quant data shows ABBV's Interest Expenses at $245.0 million in Q2 2016, $215.0 million in Q1 2016, and $208.0 million in Q4 2015.